Stock screenerAll disclosures →
EDGAR →
RMD
Conviction 43HealthcareScan · Mon, Aug 10, 2026RMD$220.06+3.83%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.66M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price220.06
Change+3.83%
Gap-0.06%
Rel volume2.67×
Avg volume1.52M
Avg $ vol319.13M
SMA 20206.56
SMA 50200.69
SMA 200230.51
Price vs 50+9.65%
Price vs 200-4.53%
MA stackmixed
50/200 cross—
Supertrendup · 204.26
RSI (14)59
MACD hist1.49
MACD crossbull · 9d
Stoch %K / %D83 / 79
ADX (14)19
+DI / −DI32 / 29
RSI divergence—
MACD divergence—
ATR %+3.52%
ADR %2.95%
52w high293.73
52w low182.82
From 52w high-25.08%
Above 52w low+20.37%
New 52w highNo
SqueezeOff
Bollinger width20.64%
%B0.82
Donchian pos83.12%
Donchian high226.12
Donchian low190.21
AVWAP (52w high)233.23
vs AVWAP high-5.65%
AVWAP (52w low)202.14
vs AVWAP low+8.86%
OBV trendFlat
Chaikin MF (20)0.38
Today vs 20d2.67×
Avg vol (14d)1.66M
Avg vol (20d)1.52M
Avg $ vol (20d)319.13M
Market cap31.92B
RS 3m (vs SPY)-3.26%
RS 6m (vs SPY)-34.75%
RS line new highNo
Trend template1/8
Technical rank42.5
1 week+2.26%
1 month+7.94%
3 months+6.43%
6 months-18.99%
1 year-21.45%
YTD-10.11%
P/E22.79
P/B4.92
P/S6.20
P/FCF19.21
EPS9.51
Div yield0.97%
ROE21.58%
ROA15.95%
Debt/Eq0.16
Current3.01
EV/EBITDA16.60
Gross margin59.36%
Net margin27.22%
Rev growth9.84%
EPS growth37.20%
Price target237.91
Target upside8.11%
Analyst ratingHold
Institutional81.02%
Ent. value31.28B
Revenue1.43B
Net income398.73M
Gross profit890.98M
Free cash flow1.66B
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out145.06M
Employees10.6K
ListedFri, Jun 2, 1995
Free float144.48M
Float %99.2%
Short interest13.54M
Days to cover7.8d
Short volume73.4%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.95 vs $2.90
Last surprise+1.7% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank42.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance224.28
Support187.43
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RMD · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
Kelly Louise Morrison house · D · MN · traded 2025-06-04 | Sell | $1K–$15K | 2025-06-04 | 2025-06-18 | |
Kelly Louise Morrison house · D · MN · traded 2025-04-28 | Sell | $1K–$15K | 2025-04-28 | 2025-05-13 | |
Rob Bresnahan house · PA · traded 2025-01-13 | Sell | $1K–$15K | 2025-01-13 | 2025-02-13 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 |
Insider activity
SEC Form 4 transactions in RMD · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Exercise | 4.99K | $730K | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Sell | 4.99K | $1.1M | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-07-07 | Exercise | 4.99K | — | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Exercise | 4.99K | $730K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Sell | 4.99K | $968K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-06-08 | Exercise | 4.99K | $0 | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Other | — | — | 2026-06-08 | 2026-06-09 |
Rider Michael J Global General Counsel · ResMed Common Stock · 2026-06-01 | Tax | 268.742 | $51K | 2026-06-01 | 2026-06-03 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-05-07 | Exercise | 4.99K | $730K | 2026-05-07 | 2026-05-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-05-07 | Sell | 4.99K | $1.0M | 2026-05-07 | 2026-05-11 |
SEC filings
EDGAR filings in RMD · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.